Selected article for: "Ct value and pool sample"

Author: Chhikara, Komal; Kanta, Poonam; Ghosh, Arnab; Prakash, Rishi Chetanya; Goyal, Kapil; Singh, Mini P
Title: Validation of SARS CoV-2 detection by real time PCR in matched pooled and deconvoluted clinical samples before and after nucleic acid extraction: A study in tertiary care hospital of North India
  • Cord-id: 2eisler0
  • Document date: 2020_9_12
  • ID: 2eisler0
    Snippet: The diagnosis of COVID-19 diseases relies on the detection of SARS CoV-2 RNA by real time RT-PCR in respiratory samples. Rapid increase in the COVID-19 cases across the world requires fast and efficient testing as testing capacity is a bottleneck in diagnosis. In this context, pooling strategy can be opted for rapid testing in a cost-effective manner. In this study the authors have optimized and compared the effect of pooling (5 & 10 samples) before and after nucleic acid extraction. It was conc
    Document: The diagnosis of COVID-19 diseases relies on the detection of SARS CoV-2 RNA by real time RT-PCR in respiratory samples. Rapid increase in the COVID-19 cases across the world requires fast and efficient testing as testing capacity is a bottleneck in diagnosis. In this context, pooling strategy can be opted for rapid testing in a cost-effective manner. In this study the authors have optimized and compared the effect of pooling (5 & 10 samples) before and after nucleic acid extraction. It was concluded that there was no significant difference in the SARS CoV-2 RNA detection in the pools prepared at sample or RNA level. Even after pooling, 10-fold dilution was detectable with 3 Ct value change in both type of pools when compared with individual samples. Hence, sample pool size of 10 can be used in low prevalent areas and testing capacity can be substantially increased.

    Search related documents:
    Co phrase search for related documents
    • acid extraction and low prevalence: 1, 2, 3, 4, 5, 6
    • acute respiratory and additional sampling: 1, 2, 3, 4
    • acute respiratory and low budget: 1, 2
    • acute respiratory and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and low prevalence area: 1, 2, 3, 4
    • acute respiratory and low prevalent: 1, 2, 3, 4, 5
    • additional sampling and low prevalence: 1